FDA Investigator Glorioso M Pama
Glorioso M Pama has inspections in 1 countries as of 21 Oct 2022. Glorioso M Pama has collaborated with a combined 771 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
24
Last Inspection Date:
21 Oct 2022
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alexandra B Pitkin,
Ana M Pietsch,
Barbara A Moss,
Brian Ravitch,
Brian S Erickson,
Bush,
Carey A Watson,
Carol S Sanchez,
Carr Sharpe,
Chelsea N Sealey,
Cori W Bitterman,
David G Whitman,
Davis,
Debra D Devlieger,
Elizabeth A Girard,
Erica Aspinwall Brown,
Ernesto E Palomar,
Francisco,
Herminio C Francisco,
Hoover,
James P Stallings,
Jinnie Kokiatkulkij,
John A Liu,
John E Urban,
John R Myung,
Judy C Nepsa,
Ka L Wong,
Kenneth S Boehnen,
Kevin T Gerrity,
Kimberly M Lichter,
Lewisjess,
Natalie J Ayoub,
Patti A Walters,
Rae B Cabral,
Raphelia Spisso,
Rebecca I Campalans,
Rochelle A Rolnik,
Rocio Guzman Velazquez,
Sandersk,
Sandra Jacquez,
Sara Jdent Acosta,
Sherry Lpurvis Wynn,
Sparky L Bartee,
Sydney S Taylor,
Thanh M Andrews,
Thomas J Scott,
Wilson M Dela Llana
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more